Geraniol

Geraniol is an acyclic monoterpene

Geraniol occurs in plant essential oils. On a cannabis analysis, the name describes a constituent detected or measured in that sample. It does not carry a patient outcome with it.

The study used cancer cells and mice

A primary study tested geraniol in human lung and skin carcinoma cell lines and in a mouse tumour model. It recorded changes in cell proliferation and tumour growth under the defined experimental conditions. Those are cell and animal findings. They are not a study of cancer treatment in people or of a geraniol-containing cannabis product.

Why the concentration still matters

A geraniol result does not show that the amount in a labelled product resembles the exposure used in the cell or mouse work. It also says nothing about the other constituents in the formulation or how the complete product behaves. The compound name is useful for reading the chemistry record, but it cannot substitute for clinical evidence.

The cited paper supports further preclinical work on geraniol. It does not establish a cancer treatment effect for people or a product response for prescribed cannabis.

Related conditions

• Neuropathic pain
• Fibromyalgia

Sources

• Geraniol in lung and skin carcinoma models (primary cell/laboratory and mouse study, PMID 33826182, DOI 10.1002/ptr.7094).